DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution

 DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution                                                       Licensing Agreement to add MeMed BV™, Immune System Based Protein Signature Test for Distinguishing between Bacterial vs. Viral Infections, to the broad DiaSorin LIAISONÒ test menu, available on LIAISONÒ analyzers SALUGGIA, Italy and HAIFA, Israel, September 8, 2020 – […]